Kelly Blackburn - 04 Feb 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role
SVP, Clinical Development
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
04 Feb 2025
Net transactions value
$0
Form type
4
Filing time
14 Feb 2025, 18:00:53 UTC
Previous filing
26 Jan 2024
Next filing
13 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVO Stock Option (Right to Buy) Award $0 +27,000 $0.000000 27,000 04 Feb 2025 Common Stock 27,000 $2.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025.